Skip to main content
. 2018 Oct 17;16(10):e05423. doi: 10.2903/j.efsa.2018.5423

Table B.1.

Summary of safety evaluation of the JECFA substances in the present group (JECFA, 2000, 2004, 2007)

FL‐no JECFA‐no EU Register name Structural formula EU MSDIa US MSDI (μg/capita per day) Classb Evaluation procedure pathc Outcome on the named compound (d or e) EFSA conclusion on the named compound (genotoxicity)

02.174

1617

2‐Methylbut‐2‐en‐1‐ol graphic file with name EFS2-16-e05423-g020.jpg 0.037

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

05.033

1216

2‐Ethylhept‐2‐enal graphic file with name EFS2-16-e05423-g021.jpg

0.012

0.1

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

05.090

1209

2‐Methylpent‐2‐enal graphic file with name EFS2-16-e05423-g022.jpg

3.4

0.2

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

05.095

1201

2‐Methylcrotonaldehyde graphic file with name EFS2-16-e05423-g023.jpg

0.61

0.2

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

05.105

1214

2‐Butylbut‐2‐enal graphic file with name EFS2-16-e05423-g024.jpg

0.0

0.01

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

05.107

1215

2‐Isopropyl‐5‐methylhex‐2‐enal graphic file with name EFS2-16-e05423-g025.jpg

0.24

0.01

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

05.126

1217

2‐Methyloct‐2‐enal graphic file with name EFS2-16-e05423-g026.jpg

0.0

7.9

Class I

A3: Intake below threshold

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure
05.130 alpha‐Sinensal graphic file with name EFS2-16-e05423-g027.jpg Not evaluated by JECFA Substance not in the Register

05.178

1227

beta‐Sinensal graphic file with name EFS2-16-e05423-g028.jpg

0.91

0.5

Class I

A3: Intake below threshold

d Substance not supported by industry
07.261 4‐Methyl‐3‐hepten‐5‐one graphic file with name EFS2-16-e05423-g029.jpg Not evaluated by JECFA Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

09.177

1207

2‐Methylallyl butyrate graphic file with name EFS2-16-e05423-g030.jpg

ND

0.2

Class I

A3: Intake below threshold

d Substance not supported by industry

09.931

1226

2,6‐Dimethyl‐2,5,7‐octariene‐1‐ol acetate graphic file with name EFS2-16-e05423-g031.jpg

1.2

7.7

Class I

A3: Intake below threshold

d Evaluated in FGE.207, as of no genotoxicity concern and evaluated through the Procedure in FGE.72Rev1

12.065

471

2,8‐Dithianon‐4‐en‐4‐carboxaldehyde graphic file with name EFS2-16-e05423-g032.jpg

0.012

0.1

Class I

JECFA evaluated at step B5: intake below 1.5 μg/person per day

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

12.079

470

2‐(Methylthiomethyl)but‐2‐enal graphic file with name EFS2-16-e05423-g033.jpg

0.024

0.1

Class I

JECFA evaluated at step B5: intake below 1.5 μg/person per day

d Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure

ND: not determined; JECFA: The Joint FAO/WHO Expert Committee on Food Additives; FL‐no: FLAVIS number; MSDI: maximised survey‐derived daily intake; FGE: Flavouring Group Evaluation.

a

EU MSDI: Amount added to food as flavour in (kg/year) × 10E9/(0.1 × population in Europe (= 375 × 10E6) × 0.6 × 365) = μg/capita per day.

b

Thresholds of concern: Class I = 1,800 μg/person/day, Class II = 540 μg/person/day, Class III = 90 μg/person per day.

c

Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.

d

No safety concern based on intake calculated by the MSDI approach of the named compound.

e

Data must be available on the substance or closely related substances to perform a safety evaluation.